PHOENIX, Dec. 18, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the...
PHOENIX, Dec. 17, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the...
PHOENIX, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Pharmaceutical-grade cannabidiol (CBD) oral solution made by...
PHOENIX, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Clinical data from a long-term safety study of pharmaceutical-grad...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
CannabisNewsWire Editorial Coverage: The cannabis industry is seeing repeated waves of growth, creating challenges for supply and distribution...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON...
Company’s Position as a Leader and Strategic Partner in Pharmaceutical Cannabinoids Strengthens with...
Company Reiterates Focus on Pharmaceutical Cannabinoids and Spray Technology PHOENIX, Nov. 05, 2018 (GLOBE...
PHOENIX, Nov. 01, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), today announced that a...
CannabisNewsWire Editorial Coverage: All eyes are on Canada and the burgeoning North American cannabis market as the flood gates open and...
PHOENIX, Oct. 22, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...
FORM 3 UNITED STATES SECURITIES AND EXCHANGE...
PHOENIX, Oct. 12, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.